tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paige Meyer, 2 are a HOLD (100%).
Analyst Paige Meyer, currently employed at CFRA, carries an average stock price target met ratio of 100% that have a potential upside of 10.75% achieved within 147 days.
Paige Meyer’s has documented 4 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DGX, Quest Diagnostics at 22-Oct-2024.
Analyst best performing recommendations are on INSP (INSPIRE MEDICAL SYSTEMS).
The best stock recommendation documented was for INSP (INSPIRE MEDICAL SYSTEMS) at 6/11/2024. The price target of $175 was fulfilled within 57 days with a profit of $9.59 (5.8%) receiving and performance score of 1.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-May-2024
$307
$34.99 (12.86%)
$330
1 months 27 days ago
(04-Aug-2026)
23/30 (76.67%)
$34.5 (12.66%)
430
Buy Since 02-Aug-2019
$320
$47.99 (17.64%)
$350
1 months 28 days ago
(03-Aug-2026)
15/21 (71.43%)
$39.54 (14.10%)
465
Hold Since 03-Jan-2023
$307
$34.99 (12.86%)
$305
2 months ago
(31-Jul-2026)
8/15 (53.33%)
$29.53 (10.64%)
291
Buy Since 09-Apr-2025
$361
$88.99 (32.72%)
$338
2 months ago
(31-Jul-2026)
0/9 (0%)
$83.53 (30.10%)
Hold Since 31-Jul-2026
$310
$37.99 (13.97%)
$304
2 months ago
(31-Jul-2026)
1/13 (7.69%)
$32.53 (11.72%)
252
What Year was the first public recommendation made by Paige Meyer?
